Certain genotypes of several genetic polymorphisms in enzymes involved in the metabolism of xenobiotics (such as CYP1A1) or in DNA repair genes have been suggested to alter the risk of breast cancer [25,26]. This evidence concerns the gene CYP1A1 and breast cancer.